neurosurgeryНейрохирургияRussian journal of neurosurgery1683-32952587-7569Издательский дом "МедИНК"10.17650/1683-3295-2024-26-3-89-94neurosurgery-1574Research ArticleНАБЛЮДЕНИЕ ИЗ ПРАКТИКИFROM PRACTICEТрудности при реперфузионной терапии инфаркта головного мозга у пациента с эритроцитозомDifficulties of reperfusion therapy of cerebral infarction in a patient with erythrocytosishttps://orcid.org/0000-0002-9680-9722ПрозоровС. А.ProzorovS. A.

Сергей Анатольевич Прозоров

129090 Москва, Большая Сухаревская пл., 3

Sergey Anatolievich Prozorov

3 Bolshaya Sukharevskaya Sq., Moscow 129090

surgeonserge@mail.ruГБУЗ г. Москвы «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского Департамента здравоохранения г. Москвы»РоссияN.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow Healthcare DepartmentRussian Federation2024070920242638994Copyright © Прозоров С.А., 20242024Прозоров С.А.Prozorov S.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therjn.com/jour/article/view/1574

Инфаркт головного мозга может возникать в результате редких болезней системы крови. Представлено клиническое наблюдение реперфузионной терапии у больного с чувашским типом наследственно-семейного эритроцитоза. Хотя больной принимал ацетилсалициловую кислоту (500 мг/cут), развился тромбоз сегмента М1 средней мозговой артерии. Несмотря на введение больному алтеплазы – рекомбинантного тканевого активатора плазминогена, тромбоаспирацию и тромбоэкстракцию, успех был кратковременным и наступил ретромбоз. Необходимо дальнейшее изучение проблемы лечения больных с инфарктом головного мозга, связанного с гематологическим заболеванием.

A brain infarction can occur as a result of rare diseases of the blood system. The clinical observation of reperfusion therapy in a patient with the Chuvash type of hereditary familial erythrocytosis is given. Although the patient took acetylsalicylic acid (500 mg per day), thrombosis of the M1 segment of the middle cerebral artery occurred. Despite the introduction of alteplase, a recombinant tissue plasminogen activator, thromboaspiration and thromboextraction to the patient, success was short-lived and retrombosis occurred. It is necessary to further study the problem of treating patients with cerebral infarction associated with hematological disease.

инфаркт головного мозгачувашский тип наследственно-семейного эритроцитозаэндоваскулярное лечениеcerebral infarctionChuvash type of hereditary familial erythrocytosisendovascular treatmentReferencesПолякова Л.А. Семейный эритроцитоз у жителей Чувашской АССР. Проблемы гематологии и переливания крови 1974;19(10):30–3.Polyakova L.A. Familial erythrocytosis in the residents of the Chuvash ASSR. Problemy gematologii i perelivaniya krovi = Problems of Hematology and Blood Transfusion 1974;19(10):30–3. (In Russ.).Gonthier A., Bogousslavsky J. [Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature (In French)]. Rev Neurol (Paris) 2004;160(11):1029–39. DOI: 10.1016/s0035-3787(04)71140-6Gonthier A., Bogousslavsky J. [Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature (In French)]. Rev Neurol (Paris) 2004;160(11):1029–39. DOI: 10.1016/s0035-3787(04)71140-6Sanahuja J., Marti-Fabregas J., Marti-Vilalta J.L. [Carotid thrombus and cerebral infarction as the initial clinical manifestation of polycythemia vera. (In Spanish)]. Neurologia 2005;20(4):194–6.Sanahuja J., Marti-Fabregas J., Marti-Vilalta J.L. [Carotid thrombus and cerebral infarction as the initial clinical manifestation of polycythemia vera. (In Spanish)]. Neurologia 2005;20(4):194–6.Tefferi A., Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 2019;94(1):133–43. DOI: 10.1002/ajh.25303Tefferi A., Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 2019;94(1):133–43. DOI: 10.1002/ajh.25303Burattini M., Falsetti L., Potente E. et al. Ischemic stroke as a presenting manifestation of polycythemia vera: a narrative review. Rev Neurosci 2021;33(3):303–11. DOI: 10.1515/revneuro-2021-0066Burattini M., Falsetti L., Potente E. et al. Ischemic stroke as a presenting manifestation of polycythemia vera: a narrative review. Rev Neurosci 2021;33(3):303–11. DOI: 10.1515/revneuro-2021-0066Gul H.L., Lau S.Y.M., Chan-Lam D., Ng J.-P. Vertebral artery thrombosis: a rare presentation of primary polycythaemia. BMJ Case Rep 2014;2014:bcr2013201347. DOI: 10.1136/bcr-2013-201347Gul H.L., Lau S.Y.M., Chan-Lam D., Ng J.-P. Vertebral artery thrombosis: a rare presentation of primary polycythaemia. BMJ Case Rep 2014;2014:bcr2013201347. DOI: 10.1136/bcr-2013-201347Benmalek R., Mechal H., Zahidi H. et al. Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report. J Med Case Rep 2021;15(1):76. DOI: 10.1186/s13256-020-02593-5Benmalek R., Mechal H., Zahidi H. et al. Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report. J Med Case Rep 2021;15(1):76. DOI: 10.1186/s13256-020-02593-5Michiels J.J., Berneman Z., Gadisseur A. et al. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera. Acta Haematol 2015;133(1):56–63. DOI: 10.1159/000360388Michiels J.J., Berneman Z., Gadisseur A. et al. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera. Acta Haematol 2015;133(1):56–63. DOI: 10.1159/000360388Roh D., Carroll J., Melmed K. et al. Endovascular treatment of cerebral venous sinus thrombosis and insights into intracranial coagulopathy. J Stroke Cerebrovasc Dis 2019;28(4):e7–e9. DOI: 10.1016/j.jstrokecerebrovasdis.2018.12.015Roh D., Carroll J., Melmed K. et al. Endovascular treatment of cerebral venous sinus thrombosis and insights into intracranial coagulopathy. J Stroke Cerebrovasc Dis 2019;28(4):e7–e9. DOI: 10.1016/j.jstrokecerebrovasdis.2018.12.015Bustamante A., Moniche-Alvarez F., Gonzalez-Marcos J.R. et al. [Recurring arterial reocclusion following endovascular recanalisation in a patient with protein S deficiency (In Spanish)]. Rev Neurol 2013;57(1):44–5.Bustamante A., Moniche-Alvarez F., Gonzalez-Marcos J.R. et al. [Recurring arterial reocclusion following endovascular recanalisation in a patient with protein S deficiency (In Spanish)]. Rev Neurol 2013;57(1):44–5.Froehler M.T. Successful treatment of cerebral venous sinus thrombosis with the Solitaire FR thrombectomy device. J Neurointerv Surg 2013;5(6):e45. DOI: 10.1136/neurintsurg-2012-010517Froehler M.T. Successful treatment of cerebral venous sinus thrombosis with the Solitaire FR thrombectomy device. J Neurointerv Surg 2013;5(6):e45. DOI: 10.1136/neurintsurg-2012-010517Alexandrov А.V., Grotta J.C. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59(6):862–7. DOI: 10.1212/wnl.59.6.862Alexandrov А.V., Grotta J.C. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59(6):862–7. DOI: 10.1212/wnl.59.6.862Li X., Gu F., Ding J. et al. The predictors and prognosis for unexpected reocclusion after mechanical thrombectomy: a metaanalysis. Ann Transl Med 2020;8(23):1566. DOI: 10.21037/atm-20-3465Li X., Gu F., Ding J. et al. The predictors and prognosis for unexpected reocclusion after mechanical thrombectomy: a metaanalysis. Ann Transl Med 2020;8(23):1566. DOI: 10.21037/atm-20-3465Mosimann P.J., Kaesmacher J., Gautschi D. et al. Predictors of unexpected early reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients. Stroke 2018;49(11):2643–51. DOI: 10.1161/STROKEAHA.118.021685Mosimann P.J., Kaesmacher J., Gautschi D. et al. Predictors of unexpected early reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients. Stroke 2018;49(11):2643–51. DOI: 10.1161/STROKEAHA.118.021685Li W., Ding J., Sui X. et al. Prognosis and risk factors for reocclusion after mechanical thrombectomy. Ann Clin Transl Neurol 2020;7(4):420–8. DOI: 10.1002/acn3.50999Li W., Ding J., Sui X. et al. Prognosis and risk factors for reocclusion after mechanical thrombectomy. Ann Clin Transl Neurol 2020;7(4):420–8. DOI: 10.1002/acn3.50999Marto J.P., Strambo D., Hajdu S.D. et al. Twenty-four-hour reocclusion after successful mechanical thrombectomy: associated factors and long-term prognosis. Stroke 2019;50(10):2960–3. DOI: 10.1161/STROKEAHA.119.026228Marto J.P., Strambo D., Hajdu S.D. et al. Twenty-four-hour reocclusion after successful mechanical thrombectomy: associated factors and long-term prognosis. Stroke 2019;50(10):2960–3. DOI: 10.1161/STROKEAHA.119.026228

The authors declare that there are no conflicts of interest present.